Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.54 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.54 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.54 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.49 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.49 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | RRM1 | P23921 | 1/20 | 0.45 |
| ▸ | NMT2 | O60551 | 1/20 | 0.45 |
| ▸ | NMT1 | P30419 | 1/20 | 0.45 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.41 |
| ▸ | CPB1 | P15086 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.37 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16384386 | 0.87 | GNAI3 (0.55) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL16575044 | 0.85 | GNAI3 (0.50) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL16575047 | 0.85 | GNAI3 (0.50) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL16575046 | 0.85 | GNAI3 (0.50) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL14001785 | 0.85 | GNAI3 (0.65) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL29300357 | 0.85 | GNAI3 (0.74) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL23073481 | 0.84 | GNAI3 (0.55) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL22746001 | 0.84 | GNAI3 (0.49) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL20073076 | 0.83 | GNAI3 (0.62) | GNAI3GNAO1GNAI1SIRT6SIRT1 | |
| SCHEMBL20169781 | 0.81 | GNAI3 (0.65) | GNAI3GNAO1GNAI1SIRT6SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10555948-B2 | Nanocarriers and their processing for diagnostics and therapeutics | RHODE ISLAND HOSPITAL (US) | 2020-02-11 | — | — | US | disclosed |
| US-20180193344-A1 | Nanocarriers And Their Processing For Diagnostics And Therapeutics | RHODE ISLAND HOSPITAL | 2018-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180193344-A1 | Nanocarriers And Their Processing For Diagnostics And Therapeutics | SYVN1, SSB, TNF | GNAI3 3187/4885GNAO1 2952/4885GNAI1 3107/4885 |
| US-10555948-B2 | Nanocarriers and their processing for diagnostics and therapeutics | SYVN1, SSB, TNF | GNAI3 3187/4885GNAO1 2952/4885GNAI1 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.